Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Active OTC stocks -- Ignore unavailable to you. Want to Upgrade?

To: KZAP who wrote (945)	11/23/1998 2:21:00 PM
From: Lance	Read Replies (1) \| Respond to of 1058

Jacobson Resonance Enterprises Inc. Applies For European CE-Mark Approval BOCA RATON, Fla., Nov. 19 /PRNewswire/ -- With the assistance of board member Alfonso Serrato, Jacobson Resonance Enterprises Inc. (OTC Bulletin Board: JRSE) announced today that it has applied for a Certificate of Conformance (commonly known as a CE-Mark) which is equivalent to seeking FDA marketing approval in the U.S. This will allow the Company to manufacture and distribute its proprietary bio-electromagnetic medical equipment in the European Common Market for the treatment and amelioration of pain. "The approval will give the Company access to a potential market of approximately 400 million people," said Dr. Jerry Jacobson, president of Jacobson Resonance Enterprises and inventor of the technology. The Company estimates that the CE-Mark will be granted by the governmental authorities in the second quarter of 1999. Following a successful symposium held in Marbella, Spain on August 21, 1998, construction began on a training and educational facility center to serve as the Corporation's European headquarters and to coordinate/respond to multiple commercial interests and applications. The grand opening is set for the end of March 1999. "We're currently completing double-blind randomized clinical trials on pain pursuant to FDA approval in the United States," added Jacobson. Jacobson Resonance Enterprises, Inc. is a leader in the emerging field of bio-electromagnetic resonance. The Company's proprietary technology known as Jacobson Resonance has applications that cut across the medical, pharmaceutical, food and beverage, construction, and environmental industries. Forward-looking statements in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to certain risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission. SOURCE Jacobson Resonance Enterprises Inc.